177 related articles for article (PubMed ID: 15068834)
21. Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
Dachineni R; Kumar DR; Callegari E; Kesharwani SS; Sankaranarayanan R; Seefeldt T; Tummala H; Bhat GJ
Int J Oncol; 2017 Dec; 51(6):1661-1673. PubMed ID: 29075787
[TBL] [Abstract][Full Text] [Related]
22. L-arginine reduces cell proliferation and ornithine decarboxylase activity in patients with colorectal adenoma and adenocarcinoma.
Ma Q; Wang Y; Gao X; Ma Z; Song Z
Clin Cancer Res; 2007 Dec; 13(24):7407-12. PubMed ID: 18094424
[TBL] [Abstract][Full Text] [Related]
23. Relationship between immunohistochemical evaluation of thymidylate synthase and proliferating cell nuclear antigen labeling index in gastrointestinal carcinoma.
Kunimoto Y; Nakamura T; Ohno M; Kuroda Y
Oncol Rep; 2004 Dec; 12(6):1163-7. PubMed ID: 15547732
[TBL] [Abstract][Full Text] [Related]
24. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
[TBL] [Abstract][Full Text] [Related]
25. Rectal epithelial cell proliferation: comparison of errors of measurement with inter-subject variance. Australian Polyp Prevention Project Investigators.
Macrae FA; Kilias D; Sharpe K; Hughes N; Young GP; MacLennan R
J Cell Biochem Suppl; 1994; 19():84-90. PubMed ID: 7823610
[TBL] [Abstract][Full Text] [Related]
26. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
27. Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer.
Miyamoto S; Ito K; Kurokawa K; Suzuki K; Suzuki K; Yamanaka H
Int J Urol; 2006 Jun; 13(6):767-72. PubMed ID: 16834658
[TBL] [Abstract][Full Text] [Related]
28. Expression of gamma-aminobutyric acid and glutamic acid decarboxylases in rat descending colon and their relation to epithelial differentiation.
Wang FY; Zhu RM; Maemura K; Hirata I; Katsu K; Watanabe M
Chin J Dig Dis; 2006; 7(2):103-8. PubMed ID: 16643338
[TBL] [Abstract][Full Text] [Related]
29. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
Reddy BS; Wang CX; Kong AN; Khor TO; Zheng X; Steele VE; Kopelovich L; Rao CV
Cancer Res; 2006 Apr; 66(8):4542-6. PubMed ID: 16618783
[TBL] [Abstract][Full Text] [Related]
30. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
31. The association between aspirin use and the incidence of colorectal cancer in women.
Allison M; Garland C; Chlebowski R; Criqui M; Langer R; Wu L; Roy H; McTiernan A; Kuller L;
Am J Epidemiol; 2006 Sep; 164(6):567-75. PubMed ID: 16847042
[TBL] [Abstract][Full Text] [Related]
32. Lack of chemoprevention of dietary Agaricus blazei against rat colonic aberrant crypt foci.
Ziliotto L; Barbisan LF; Rodrigues MA
Hum Exp Toxicol; 2008 Jun; 27(6):505-11. PubMed ID: 18784204
[TBL] [Abstract][Full Text] [Related]
33. Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences.
Hoh C; Boocock D; Marczylo T; Singh R; Berry DP; Dennison AR; Hemingway D; Miller A; West K; Euden S; Garcea G; Farmer PB; Steward WP; Gescher AJ
Clin Cancer Res; 2006 May; 12(9):2944-50. PubMed ID: 16675592
[TBL] [Abstract][Full Text] [Related]
34. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156
[TBL] [Abstract][Full Text] [Related]
35. Epidemiological use of rectal proliferation measures.
Baron JA; Wargovich MJ; Tosteson TD; Sandler R; Haile R; Summers R; van Stolk R; Rothstein R; Weiss J
Cancer Epidemiol Biomarkers Prev; 1995; 4(1):57-61. PubMed ID: 7894325
[TBL] [Abstract][Full Text] [Related]
36. Human studies of calcium supplementation and colorectal epithelial cell proliferation.
Bostick RM
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):971-80. PubMed ID: 9367073
[TBL] [Abstract][Full Text] [Related]
37. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
38. Chemopreventive effects of rofecoxib and folic acid on gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats.
Fei SJ; Xiao SD; Peng YS; Chen XY; Shi Y
Chin J Dig Dis; 2006; 7(3):134-40. PubMed ID: 16808793
[TBL] [Abstract][Full Text] [Related]
39. Diabetes, colorectal cancer and cyclooxygenase 2 inhibition.
Smith CJ; McKay GA; Fisher M
Int J Clin Pract; 2008 May; 62(5):810-5. PubMed ID: 18373616
[TBL] [Abstract][Full Text] [Related]
40. Amaranthin lectin binding in the rat colon: response to dietary manipulation.
Atillasoy EO; Kapetanakis A; Itzkowitz SH; Holt PR
Mt Sinai J Med; 1998 Mar; 65(2):146-53. PubMed ID: 9520519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
